What is the address of MG MEDICAL – IMMO INVEST PARTNER?

The registered office of MG MEDICAL – IMMO INVEST PARTNER is located at Woluwedal 60B, 1200 Sint-Lambrechts-Woluwe.

Is MG MEDICAL – IMMO INVEST PARTNER still active?

Yes. According to the CBE (16 September 2026) MG MEDICAL – IMMO INVEST PARTNER is active, legal situation “Normale toestand”, started on 3 August 2018.

Is MG MEDICAL – IMMO INVEST PARTNER registered on Peppol?

No, MG MEDICAL – IMMO INVEST PARTNER is currently not registered on the Peppol network.

What is the enterprise number of MG MEDICAL – IMMO INVEST PARTNER?

The enterprise number of MG MEDICAL – IMMO INVEST PARTNER is BE0700637928.

When was MG MEDICAL – IMMO INVEST PARTNER founded?

MG MEDICAL – IMMO INVEST PARTNER was founded on 3 August 2018.

Who are the directors of MG MEDICAL – IMMO INVEST PARTNER?

According to the 2024 annual accounts, the directors of MG MEDICAL – IMMO INVEST PARTNER are: IRNO SRL, Rima ABOU-HACEM.

Is MG MEDICAL – IMMO INVEST PARTNER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 August 2018; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did MG MEDICAL – IMMO INVEST PARTNER make in 2024?

MG MEDICAL – IMMO INVEST PARTNER posted a profit after taxes of € 299,470 in financial year 2024.

What is the revenue of MG MEDICAL – IMMO INVEST PARTNER?

As a small company, MG MEDICAL – IMMO INVEST PARTNER is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 401,097.

MG MEDICAL – IMMO INVEST PARTNER (Private Limited)

Dossier MG MEDICAL – IMMO INVEST PARTNER, printed on 16 September 2026 from databakkes.be/en/0700637928/mg-medical-immo-invest-partner. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 43 % of short-term debt in 2024; threshold 65 %.
Board fully replaced NBB

No director from three years ago is still active according to annual account 2024.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

MG MEDICAL – IMMO INVEST PARTNER from Sint-Lambrechts-Woluwe, company number BE0700637928, closed financial year 2024 with a result of € 299,470 after tax. For that financial year MG MEDICAL – IMMO INVEST PARTNER recorded a gross margin of € 401,097 and equity of € 1.3 million. Compared with financial year 2023, the result moved from € 67,257 to € 299,470. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2025.

What it is worth Growing

€ 1.3 million

▲ 29% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 299,470

▲ € 232,212 vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 41,015

▼ 76% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 924,111.

People and assets in 2024

Vehicles and equipment

€ 3,322

▼ 63% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 36 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.8 million

▼ 7% vs 2023

€ 49,428 is repaid this year. At this pace the long-term loan is gone in ≈ 36 years.

Owed to suppliers

€ 19,686

▲ 13% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 515,572 Gross margin 2021: € 515,572 First fiscal year in the series	€ 199,282 Gross margin 2022: € 199,282 ▼ 61% vs 2021 (€ 515,572) Unfavourable step	€ 865,959 Gross margin 2023: € 865,959 ▲ € 666,677 vs 2022 (€ 199,282) Favourable step	€ 401,097 Gross margin 2024: € 401,097 ▼ 54% vs 2023 (€ 865,959) Unfavourable step	▼ 54%
Profit after taxes	€ 247,055 Profit after taxes 2021: € 247,055 First fiscal year in the series	€ -79,484 Profit after taxes 2022: € -79,484 ▼ € 326,539 vs 2021 (€ 247,055) Unfavourable step	€ 67,257 Profit after taxes 2023: € 67,257 ▲ € 146,741 vs 2022 (€ -79,484) Favourable step	€ 299,470 Profit after taxes 2024: € 299,470 ▲ € 232,212 vs 2023 (€ 67,257) Favourable step	▲ € 232,212
Equity	€ 1,043,905 Equity 2021: € 1,043,905 First fiscal year in the series	€ 964,420 Equity 2022: € 964,420 ▼ 8% vs 2021 (€ 1,043,905) Unfavourable step	€ 1,031,678 Equity 2023: € 1,031,678 ▲ 7% vs 2022 (€ 964,420) Favourable step	€ 1,331,148 Equity 2024: € 1,331,148 ▲ 29% vs 2023 (€ 1,031,678) Favourable step	▲ 29%
Total debts	€ 6,094,960 Total debts 2021: € 6,094,960 First fiscal year in the series	€ 4,147,806 Total debts 2022: € 4,147,806 ▼ 32% vs 2021 (€ 6,094,960) Favourable step	€ 4,123,396 Total debts 2023: € 4,123,396 ▼ 1% vs 2022 (€ 4,147,806) Favourable step	€ 3,322,276 Total debts 2024: € 3,322,276 ▼ 19% vs 2023 (€ 4,123,396) Favourable step	▼ 19%
Cash	€ 558,897 Cash 2021: € 558,897 First fiscal year in the series	€ 50,551 Cash 2022: € 50,551 ▼ 91% vs 2021 (€ 558,897) Unfavourable step	€ 168,981 Cash 2023: € 168,981 ▲ 234% vs 2022 (€ 50,551) Favourable step	€ 41,015 Cash 2024: € 41,015 ▼ 76% vs 2023 (€ 168,981) Unfavourable step	▼ 76%
Land & buildings	€ 3,984,394 Land & buildings 2021: € 3,984,394 First fiscal year in the series	€ 3,504,916 Land & buildings 2022: € 3,504,916 ▼ 12% vs 2021 (€ 3,984,394) Unchanged	€ 715,469 Land & buildings 2023: € 715,469 ▼ 80% vs 2022 (€ 3,504,916) Unchanged	€ 663,303 Land & buildings 2024: € 663,303 ▼ 7% vs 2023 (€ 715,469) Unchanged	▼ 7%
Retained profit	€ 636,868 Retained profit 2021: € 636,868 First fiscal year in the series	€ 557,384 Retained profit 2022: € 557,384 ▼ 12% vs 2021 (€ 636,868) Unfavourable step	€ 624,641 Retained profit 2023: € 624,641 ▲ 12% vs 2022 (€ 557,384) Favourable step	€ 924,111 Retained profit 2024: € 924,111 ▲ 48% vs 2023 (€ 624,641) Favourable step	▲ 48%
Bank debt	€ 2,124,331 Bank debt 2021: € 2,124,331 First fiscal year in the series	€ 2,002,074 Bank debt 2022: € 2,002,074 ▼ 6% vs 2021 (€ 2,124,331) Favourable step	€ 1,901,680 Bank debt 2023: € 1,901,680 ▼ 5% vs 2022 (€ 2,002,074) Favourable step	€ 1,770,546 Bank debt 2024: € 1,770,546 ▼ 7% vs 2023 (€ 1,901,680) Favourable step	▼ 7%
Balance sheet total	€ 7,138,865 Balance sheet total 2021: € 7,138,865 First fiscal year in the series	€ 5,112,226 Balance sheet total 2022: € 5,112,226 ▼ 28% vs 2021 (€ 7,138,865) Unchanged	€ 5,155,074 Balance sheet total 2023: € 5,155,074 ▲ 1% vs 2022 (€ 5,112,226) Unchanged	€ 4,653,424 Balance sheet total 2024: € 4,653,424 ▼ 10% vs 2023 (€ 5,155,074) Unchanged	▼ 10%

Key figures of MG MEDICAL – IMMO INVEST PARTNER, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to MG MEDICAL – IMMO INVEST PARTNER?

What happened at MG MEDICAL – IMMO INVEST PARTNER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 22, 2025 New annual accounts for financial year 2024: profit of € 299,470 (▲ € 232,212 vs 2023). filed late Source: NBB ↗
2024 IRNO SRL became a director. NBB
2024 Rima ABOU-HACEM stepped down as director. NBB
Aug 3, 2018 New establishment in Sint-Lambrechts-Woluwe. KBO
2018 Rima ABOU-HACEM became a director. NBB
Aug 3, 2018 Start of the company according to the CBE. KBO

In short

From € 247,055 profit in 2021 to € 299,470 profit in 2024.

Paid € 1,003 in corporate taxes since 2021.

Best year ever: 2024, with € 299,470 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MG MEDICAL – IMMO INVEST PARTNER? We notify you, reason included.

Follow MG MEDICAL – IMMO INVEST PARTNER

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit